CEMIPLIMAB-RWLC

Search structure
Trade Names:
Status: Approved (2018)
Entry Type: Antibody
Molecule Category: UNKNOWN

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
12.93
Immune system disorders
8.13
Infections and infestations
7.07
Hepatobiliary disorders
6.8
Musculoskeletal and connective tissue disorders
6.8
Respiratory, thoracic and mediastinal disorders
6.67
Skin and subcutaneous tissue disorders
6.13
Investigations
5.73
Nervous system disorders
4.93
Injury, poisoning and procedural complications
4.67
Renal and urinary disorders
4.27
Psychiatric disorders
3.47
Vascular disorders
3.47
Blood and lymphatic system disorders
3.2
Cardiac disorders
3.07
Gastrointestinal disorders
2.93
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
2.93
Metabolism and nutrition disorders
2.8
CONTENTS